These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14988864)

  • 1. Long-term oral tacrolimus in refractory to infliximab fistulizing Crohn's disease: comments from Spanish experience.
    González Lama Y; Abreu LE; Vera MI; de la Revilla J; Fernandez-Puga N; Escartin P
    Gastroenterology; 2004 Mar; 126(3):942-3; author reply 943. PubMed ID: 14988864
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient with Fistulizing Crohn's Disease with Nonresponse to Infliximab Subsequently Responds to Infliximab After Short-term Addition of Tacrolimus.
    Lee S; Clark-Snustad K
    Inflamm Bowel Dis; 2021 Jan; 27(2):e20-e22. PubMed ID: 33119736
    [No Abstract]   [Full Text] [Related]  

  • 3. Retreatment and maintenance therapy with infliximab in fistulizing Crohn's disease.
    Rodrigo L; Pérez-Pariente JM; Fuentes D; Cadahia V; García-Carbonero A; Niño P; de Francisco R; Tojo R; Moreno M; González-Ballina E
    Rev Esp Enferm Dig; 2004 Aug; 96(8):548-54; 554-8. PubMed ID: 15449986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
    González-Lama Y; Abreu L; Vera MI; Pastrana M; Tabernero S; Revilla J; Durán JG; Escartin P
    Inflamm Bowel Dis; 2005 Jan; 11(1):8-15. PubMed ID: 15674108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab in treatment of Crohn's disease: the Milan experience.
    Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G
    Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to infliximab in patients with fistulizing Crohn's disease.
    Luna-Chadid M; Pérez Calle JL; Mendoza JL; Vera MI; Bermejo AF; Sánchez F; López San Román A; Froilán C; González-Lara V; García-Paredes J; Fernández-Blanco I; Abreu L; Casis B; Solís Herruzo JA; Gisbert JP; Maté Jiménez J
    Rev Esp Enferm Dig; 2004 Jun; 96(6):379-81; 382-4. PubMed ID: 15230667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.
    Schröder O; Blumenstein I; Schulte-Bockholt A; Stein J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):295-301. PubMed ID: 14984376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab in fistulizing Crohn's disease.
    Osterman MT; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication].
    Lee KM; Kim JS; Shin DH; Cheong JY; Yoo BM; Kim JK; Lee KJ; Hahm KB; Kim JH; Cho SW
    Korean J Gastroenterol; 2004 Nov; 44(5):259-66. PubMed ID: 15564805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
    Hlavaty T; Pierik M; Henckaerts L; Ferrante M; Joossens S; van Schuerbeek N; Noman M; Rutgeerts P; Vermeire S
    Aliment Pharmacol Ther; 2005 Oct; 22(7):613-26. PubMed ID: 16181301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing anti-TNF treatment in inflammatory bowel disease.
    Rutgeerts P; Van Assche G; Vermeire S
    Gastroenterology; 2004 May; 126(6):1593-610. PubMed ID: 15168370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closure of jejuno-colic fistula in Crohn's disease with infliximab.
    Sood A; Midha V; Sood N
    Indian J Gastroenterol; 2001; 20(4):164-5. PubMed ID: 11497186
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
    Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
    Paré P
    Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
    Fiocchi C
    N Engl J Med; 2004 Feb; 350(9):934-6. PubMed ID: 14985492
    [No Abstract]   [Full Text] [Related]  

  • 17. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice.
    Cadahia V; García-Carbonero A; Vivas S; Fuentes D; Niño P; Rebollo P; Rodrigo L
    Rev Esp Enferm Dig; 2004 Jun; 96(6):369-74; 374-8. PubMed ID: 15230666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.